← FDA Drug Approvals (Drugs@FDA)

DIFFERIN

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2010-03-17

Drug application

FDA Application #

NDA022502

Application type

New Drug Application

Brand name

DIFFERIN

Generic name

Adapalene

Active ingredients

ADAPALENE

Dosage form

LOTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

GALDERMA LABS LP

First approval

2010-03-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown